v3.26.1
Segment Reporting
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Reporting

18. Segment Reporting — The Company operates as a single operating segment, which is the business of developing, manufacturing and distributing chemical, biological and biorational products for agricultural, commercial and consumer uses. The Company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection.

The Company’s Chief Operating Decision Maker ("CODM") is the Chief Executive Officer, who manages the Company’s operations based on consolidated financial information for purposes of evaluating financial performance and allocating resources. The financial information reviewed by the CODM includes revenue by product line and region, and key expense categories that are regularly provided for the consolidated company. The accounting policies of the Company’s single operating segment are the same as those described in the summary of significant accounting policies. Although there are other measures of operating performance used by the CODM, the Company concluded that consolidated operating (loss) income is the measure required to be disclosed as the segment measure of profit or loss. Operating (loss) income is utilized to evaluate to monitor budget versus actual results in order to gain more depth and understanding of the factors driving the business. When evaluating the Company’s financial performance, the following table sets forth significant expense categories regularly provided to the CODM:

 

 

 

For the three months
ended March 31

 

 

 

2026

 

 

2025

 

Net sales

 

$

123,568

 

 

$

115,800

 

Cost of sales

 

 

 

 

 

 

Material and other costs

 

 

(74,920

)

 

 

(76,024

)

Warehousing, handling, and outbound freight

 

 

(10,231

)

 

 

(9,585

)

Total cost of sales

 

 

(85,151

)

 

 

(85,609

)

Gross profit

 

 

38,417

 

 

 

30,191

 

Operating expenses

 

 

 

 

 

 

Selling, general and administrative

 

 

(27,713

)

 

 

(26,628

)

Research, product development and regulatory

 

 

(5,271

)

 

 

(5,682

)

Product liability claims

 

 

(81

)

 

 

—

 

Transformation

 

 

(2,804

)

 

 

(2,191

)

Asset impairments

 

 

(659

)

 

 

—

 

Operating income (loss)

 

 

1,889

 

 

 

(4,310

)

Change in fair value of an equity investment

 

 

(120

)

 

 

—

 

Interest expense, net

 

 

(5,790

)

 

 

(3,765

)

Loss before provision for income taxes

 

 

(4,021

)

 

 

(8,075

)

Income tax expense

 

 

(124

)

 

 

(387

)

Net loss

 

$

(4,145

)

 

$

(8,462

)

Asset categories provided to the CODM are consistent with those reported on the condensed consolidated balance sheet.